| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
1993-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a26a50f5f3a577dd02871d22d64bfe56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_880fab4965e7b251bf014e91b155ca24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43e5b4b6df64566a3d0ce00b2708e74b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d870509bb155139171ae4bb1ec9bc85f |
| publicationDate |
1993-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9317705-A1 |
| titleOfInvention |
Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| abstract |
Disclosed are methods for selectively deglycosylating HIV-1 envelope protein which retain their ability to support viral infectivity. The deglycosylation is achieved by generating recombinant HIV-1 envelope glycoproteins which have primary amino acid sequence mutations in the N-linked glycosylation consensus sequences. Also disclosed are vaccines and antibodies to the mutant recombinant HIV-1 envelope glycoproteins. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2829150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6908617-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9924464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020755-A1 |
| priorityDate |
1992-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |